Mephedrone: Use, subjective effects and health risks

Addiction

Volumn 106, Issue 11, 2011, Pages 1991-1996

  Winstock, Adam ^a,b   Mitcheson, Luke ^a   Ramsey, John ^b   Davies, Susannah ^b   Puchnarewicz, Malgorzata ^b   Marsden, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Abuse; Cathinone; Dependence; Legal highs; Mephedrone; Risks; Toxicology

Indexed keywords

4' METHYLMETHCATHINONE; ALKALOID; CATHINONE; CENTRAL STIMULANT AGENT; DESIGNER DRUG; DRUG DERIVATIVE; METHAMPHETAMINE;

ADDICTION; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DANCING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; MUSIC; SUBSTANCE ABUSE; TELEPHONE; UNITED KINGDOM; URINE; WITHDRAWAL SYNDROME;

ADULT; ALKALOIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-SECTIONAL STUDIES; DANCING; DESIGNER DRUGS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GREAT BRITAIN; HUMANS; MALE; METHAMPHETAMINE; MUSIC; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TELEPHONE;

EID: 79960603129     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03502.x     Document Type: Article

References (13)

1. Psychonaut Web Mapping Research Group. Mephedrone Report. London, UK: Institute of Psychiatry, King's College London; 2000.
2. Kalix P. Cathinone, a natural amphetamine. Pharmacol Toxicol 1992; 70: 77-86.
3. Winstock A. R., Griffiths P., Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 2001; 64: 9-17.
4. Winstock A. R., Mitcheson L. R., Deluca P., Davey Z., Corazza O., Schifano F. Mephedrone, new kid for the chop? Addiction 2011; 106: 154-61.
5. American Psychiatric Association. Diagnostic and Statistical Manual (DSM-IV-TR). 2000.
6. Cottler L. B. Composite International Diagnostic Interview-Substance Abuse Module (SAM). St Louis, MO: Department of Psychiatry, Washington University School of Medicine; 2000.
7. Schifano F., Albanese A., Fergus S., Stair J. L., Deluca P., Corazza O. etal. Mephedrone 4-methylmethcathinone 'meow meow': chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011; 214: 593-602.
8. Dargan P. I., Albert S., Wood D. M. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Q J Med 2010; 103: 875-9.
9. Brunt T. M., Poortman A., Niesink R. J., van den Brink W. Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol 2010; Epub ahead of print 8 September.
10. Topp L., Breen C., Kaye S., Darke S. Adapting the illicit drug reporting system (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'. Drug Alcohol Depend 2004; 73: 189-97.
11. Davies C., English L., Lodwick A., McVeigh J., Bellis M. A. United Kingdom Drug Situation: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2010. UK Focal Point On Drugs. Available at: (accessed 28 April 2011; archived by Webcite at).
12. Winstock A. R., Marsden J., Mitcheson L. What should be done about mephedrone. BMJ 2010; 340: c1605.
13. Winstock A. R., Mitcheson L., Marsden J. Mephedrone-still available and twice the price. Lancet 2010; 376: 1537.